Market Tracker

01/16 7:27am ET

Mesoblast Ltd (NASDAQ:MESO)

6.23
Delayed Data
As of Jan 13
 +0.2186 / +3.64%
Today’s Change
3.50
Today|||52-Week Range
10.89
+16.42%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close6.01
Today’s open6.10
Day’s range5.94 - 6.29
Volume18,592
Average volume (3 months)16,696
Market cap$496.0M
Dividend yield--
Data as of 3:56pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)+96.32%
Earnings growth (this year)-467.25%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+143.13%
P/E ratio--
Price/Sales6.89
Price/Book0.89

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp0.000.00%
CFMSConforMIS Inc+0.03+0.35%
OFIXOrthofix Internation...+0.39+1.06%
DSCIDerma Sciences Inc0.000.00%
Data as of 4:02pm ET, 01/13/2017

Financials

Next reporting dateFebruary 27, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$41.5M
Annual profit (last year)-$4.1M
Net profit margin-9.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts